Personalized Medicine for Pulmonary Hypertension: The Future Management of Pulmonary Hypertension Requires a New Taxonomy

Wilkins Martin R.

首页> 外文期刊>Clinics in chest medicine >Personalized Medicine for Pulmonary Hypertension: The Future Management of Pulmonary Hypertension Requires a New Taxonomy

【24h】

Personalized Medicine for Pulmonary Hypertension: The Future Management of Pulmonary Hypertension Requires a New Taxonomy

机译：个性化药物用于肺动脉高压：肺动脉高压的未来管理需要新的分类法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinics in chest medicine》 |2021年第1期|共10页
作者
Wilkins Martin R.;
展开▼
作者单位

Imperial Coll London Hammersmith Hosp Natl Heart &

Lung Inst Du Cane Rd London W12 0NN England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词
Pulmonary hypertension; Precision medicine; Genetics; Endophenotypes; Deep-phenotyping;

机译：肺动脉高压;精确药物;遗传学;内心型;深表型;

相似文献

外文文献
中文文献
专利

1. Management of persistent pulmonary hypertension in newborns with ECMO support: a single center's experience [J] . Li-Fen Ye, Yong Fan, Qiang Shu, 世界儿科杂志（英文版） . 2019,第001期
2. Management of persistent pulmonary hypertension in newborns with ECMO support: a single center''''s experience [J] . Li-Fen Ye1, Yong Fan1, Qiang Shu1, 世界儿科杂志(英文版) . 2019,第001期
3. Targeted Therapy Is Required for Management of Pulmonary Arterial Hypertension After Defect Closure in Adult Patients With Atrial Septal Defect and Associated Pulmonary Arterial Hypertension [J] . Fujino Takeo, Yao Atsushi, Hatano Masaru, International heart journal . 2015,第1期

机译：成年房间隔缺损及相关性肺动脉高压患者缺损闭合后肺动脉高压的治疗需要靶向治疗
4. Targeted Therapy Is Required for Management of Pulmonary Arterial Hypertension After Defect Closure in Adult Patients With Atrial Septal Defect and Associated Pulmonary Arterial Hypertension [J] . Takeo Fujino, Atsushi Yao, Masaru Hatano, International heart journal . 2015,第1期

机译：成年房间隔缺损和相关性肺动脉高压患者缺损闭合后肺动脉高压的治疗需要靶向治疗
5. Proteomics of pulmonary hypertension: Could personalized profiles lead to personalized medicine? [J] . Proteomics. Clinical applications . 2015,第1a2期

机译：肺动脉高压的蛋白质组学：个性化的型材可以导致个性化的药物？
6. The Great Pretender: Pulmonary Hypertension - Unusual Cases and Complicated Clinical Courses in Pulmonary Hypertension Patients [C] . Conference of the American College of Veterinary Internal Medicine (ACVIM) . 2017

机译：伟大的孕妇：肺动脉高压 - 肺动脉高压患者的异常案例和复杂的临床课程
7. Pulmonary disease in scleroderma: Combined interstitial lung disease and pulmonary hypertension and predictors of pulmonary hypertension. [D] . Chang, Betty. 2003

机译：硬皮病中的肺部疾病：间质性肺部疾病和肺动脉高压的结合以及肺动脉高压的预测因子。
8. Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE) [O] . Alexandra Arvanitaki, Maria Boutsikou, Anastasia Anthi, 2019

机译：肺动脉高压的流行病学和初步处理：古希腊肺动脉高压研究（HOPE）的真实数据
9. Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE) [O] . Alexandra Arvanitaki, Maria Boutsikou, Anastasia Anthi, 2019

机译：肺动脉高压的流行病学和初始管理：来自希腊肺动脉高压登记处的真实数据（希望）
10. Metabolic and Epigenetic Interactions Regulate Vascular Phenotypic Change and Maintenance in Pulmonary Hypertension. [R] . Stenmark, K. 2016

机译：代谢和表观遗传相互作用调节肺动脉高血压的血管表型变化和维持。

Personalized Medicine for Pulmonary Hypertension: The Future Management of Pulmonary Hypertension Requires a New Taxonomy

著录项

相似文献

相关主题

期刊订阅